Ophthotech (NASDAQ:OPHT)

CAPS Rating: 4 out of 5

OPHT News and Commentary

Caps

How do you think OPHT will perform against the market?

Add Stock to CAPS Watchlist

All Players

48 Outperform
3 Underperform
 

All-Star Players

14 Outperform
1 Underperform
 

Wall Street

1 Outperform
1 Underperform
 

Top OPHT Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

usubanas (99.61)
Submitted November 28, 2016

I predict a failure in p3

OPHT VS S&P 500 (SPY)

OPHT Summary

Recent Community Commentary

Read the most recent pitches from players about OPHT.

Recs

0
Member Avatar pchop12316 (92.09) Submitted: 7/9/2018 10:34:42 AM : Outperform Start Price: $2.77 OPHT Score: -6.50

likely to thrive very shortly

Recs

0
Member Avatar SaintCroix (99.40) Submitted: 1/11/2018 8:51:07 PM : Outperform Start Price: $2.77 OPHT Score: -7.31

Another penny stock I found using Joel Greenblatt's "magic formula" screens. This is a very respectable biotech that got obliterated when one of their big drugs failed two phase 3 trials. They specialize in drugs that treat various diseases of the eye. This stock traded at $78 a share two years ago. Now it's down to $2 a share, and only one analyst was on the last quarterly conference call.

Market cap? $100 million dollars

Profit margins? 26%

$180 million in cash

$125 million debt

The company has no approved drugs. They are still receiving hefty cash milestone payments from big pharma. For instance, in Q3 they received a nice $205 million check from Novartis.

Another eye drug, Zimura, is in a phase 2/3 trial for dry AMD (age-related macular degeneration). The AMD market is estimated to exceed $10 billion dollars by 2023.

At least 3 penny stocks on Greenblatt's screens look very interesting to me: MEET, ICON and this biotech.

Recs

0
Member Avatar oscillation (77.84) Submitted: 12/24/2016 11:18:25 AM : Outperform Start Price: $4.81 OPHT Score: -69.72

nev

Leaderboard

Find the members with the highest scoring picks in OPHT.

Score Leader

biotechf

biotechf (28.77) Score: +145.29

The Score Leader is the player with the highest score across all their picks in OPHT.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
biotechf 28.77 2/8/2016 Underperform 5Y $48.44 -94.59% +50.70% +145.29 0 Comment
chushogi 66.98 12/14/2016 Underperform 5Y $4.92 -46.75% +23.12% +69.87 0 Comment
Under5 41.77 6/1/2017 Outperform 5Y $2.27 +15.42% +15.70% -0.28 0 Comment
odocoileus 56.93 7/10/2018 Outperform 5Y $2.73 -4.03% +0.56% -4.59 0 Comment
pchop12316 92.09 7/9/2018 Outperform 5Y $2.77 -5.42% +1.08% -6.50 1 Comment
drhowe144 < 20 1/12/2018 Outperform 3Y $2.78 -5.76% +1.28% -7.04 0 Comment
rwadington 86.24 2/1/2018 Outperform 1Y $2.84 -7.75% -0.56% -7.19 0 Comment
SaintCroix 99.40 1/11/2018 Outperform 5Y $2.77 -5.42% +1.90% -7.31 1 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. zzlangerhans 99.57 7/9/2018 Outperform 1Y $2.85 -8.07% +1.23% -9.30 0 Comment
gunda7907 43.00 7/25/2017 Outperform 5Y $2.56 +2.34% +13.03% -10.69 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer 85.60 10/20/2016 Underperform 3W $36.57 -92.84% +30.90% +123.73 0 Comment
TrackJPMorgan 87.47 6/2/2016 Outperform NS $57.99 -95.48% +33.44% -128.92 0 Comment

Featured Broker Partners


Advertisement